journal article·2021-09

Powder X-ray diffraction data for dimethylarsinic acid, (CH 3 ) 2 AsO(OH)

Joel W. Reid

Powder Diffraction· Volume 36· Issue 3
Publisher page

Abstract

Synchrotron powder diffraction data is presented for the monoclinic polymorph of dimethylarsinic acid, (CH 3 ) 2 AsO(OH) (DMA V ). Rietveld refinement with GSASII yielded lattice parameters of a = 15.9264(15) Å, b = 6.53999(8) Å, c = 11.3401(9) Å, and β = 125.8546(17)° ( Z = 8, space group C 2/ c ). The Rietveld-refined structure was compared with both a density functional theory (DFT)-optimized structure and the published, low-temperature single-crystal structure, and all three structures exhibited excellent agreement. The triclinic polymorph of DMA V was also DFT optimized with CRYSTAL17 to determine the positions of the hydrogen atoms. Monoclinic DMA V forms zigzag chains parallel to the b- axis with adjacent DMA V molecules connected by an O–H⋯O bond, whereas triclinic DMA V forms dimers connected by two O–H⋯O bonds.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Crystal Structures and Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. 10.1107/S160057751400557810.1107/S1600577514005578 ↗
2. 10.1021/ci049780b10.1021/ci049780b ↗
3. 10.1016/j.jhydrol.2012.10.01310.1016/j.jhydrol.2012.10.013 ↗
4. 10.1002/wcms.136010.1002/wcms.1360 ↗
5. 10.1107/S160053681102550510.1107/S1600536811025505 ↗
6. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
7. 10.1107/S002188988708709010.1107/S0021889887087090 ↗
8. 10.1063/1.338234410.1063/1.3382344 ↗
9. 10.1063/1.46491310.1063/1.464913 ↗
10. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration10.1080/009841098159385 ↗
11. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
12. 10.1201/b10772-410.1201/b10772-4 ↗
13. 10.1016/j.yrtph.2006.09.00510.1016/j.yrtph.2006.09.005 ↗
14. Agency for Toxic Substances and Disease Registry, ATSDR (2020). Priority list of hazardous substances. Available at: http://www.atsdr.cdc.gov/SPL/index.html.
15. 10.1063/1.46788210.1063/1.467882 ↗
16. 10.1186/1758-2946-4-1710.1186/1758-2946-4-17 ↗
17. 10.1107/S002188989501492010.1107/S0021889895014920 ↗
18. 10.1107/S002188981103897010.1107/S0021889811038970 ↗
19. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
20. 10.1021/es202749h10.1021/es202749h ↗
21. 10.1021/acs.est.8b0030010.1021/acs.est.8b00300 ↗
22. 10.1039/jr965000446610.1039/jr9650004466 ↗
23. 10.1002/jcc.2315310.1002/jcc.23153 ↗
24. 10.1021/jp210093n10.1021/jp210093n ↗
25. 10.1016/j.jhazmat.2012.10.02710.1016/j.jhazmat.2012.10.027 ↗
26. 10.1017/S088571561900081210.1017/S0885715619000812 ↗
27. Carcinogenic and systemic health effects associated with arsenic exposure—a critical review